Bayer Says Parkinson’s Stem Cell Therapy Improves Symptoms in Initial Trial

Bayer said an experimental stem cell therapy developed by its US subsidiary BlueRock had shown signs of easing Parkinson’s disease symptoms in an early 12-patient trial.